Articles
Abbott, F M, ‘First report (final) to the Committee on International Trade Law of the International Law Association on the subject of parallel importation’, Journal of International Economic Law, 607 (1998).
Abbott, F M, ‘TRIPS II, Asia and the Pharmaceutical War: Implications for Innovation and Access’. Stanford Center for International Development, Working Paper No 308, (2006).
Abbott, F M, ‘The Doha Declaration on the TRIPS Agreement and public health: Lighting a dark corner at the WTO’, Journal of International Economic Law, 5:2 (2002), 505.
Abbott, F M and Reichman, Jerome H, ‘The Doha round’s public health legacy: Strategies for the production and diffusion of patented medicines under the amended TRIPS provisions’, Journal of International Economic Law, 10:4 (2007), 921–87.
Abbott, K W, ‘Hard and soft law in international governance’, International Organizations, 54 (2000), 421.
Alford, D E, ‘Basle Committee minimum standards: International regulatory response to the failure of BCCI’, George Washington Journal of International Law and Economics, 241 (1992), 246.
Alston, P, ‘Out of the abyss: The challenges confronting the new U.N. committee on economic, social and cultural rights’, Human Rights Quarterly, 9:3 (1987), 332–81.
Alston, P, ‘The United Nations specialized agencies and implementation of the international covenant on economic social and cultural rights’, Columbia Journal of Transnational Law, 18:79 (1979).
Alston, P and Quinn, G, ‘The nature and scope of state parties’ obligations under the international covenant on economic social and cultural rights’, Human Rights Quarterly, 9 (1987), 156–229.
Anderson, R M et al., ‘The spread of HIV-1 in Africa: Sexual contact patterns and the predicted demographic impact of AIDS’, Nature, 352 (1991), 581–9. [DOI: 10.1038/352581a0] [PubMed: 1865922].
Andorno, R, ‘The invaluable role of soft law in the development of universal norms in bioethics.’ Available from www.unesco.de/1507.html&l=0 last accessed 20 June 2010. Andrus, J D, Fleming, C and Knox, C, et al., ‘HIV testing in prisoners: Is mandatory testing mandatory?’, AJPH, 79:7 (1989), 840–2.
Ankrah, E et al. ‘AIDS and the social side of health’, Social Science and Medicine, 32:9 (1994), 967–80.
Annas, G, ‘Detention of HIV-positive Haitians at Guantanamo: Human rights and medical care’. New England Journal of Medicine, 329:8 (1993), 589.
Arangio-Ruiz, G, ‘The normative role of the General Assembly in the United Nations and the Decision of Principles of friendly relations’, RDC, 137:3 (1972), 419–44.
Armstrong, S, ‘Women hit hardest by HIV in divided South Africa’, New Scientist, 139:1880 (1993), 10.
Asad, T, ‘Ethnographic representation, statistics, and modern power’, Social Research, 61:1 (1994), 55–88.
Atler, K J, ‘Resolving or exacerbating disputes? The WTO’s new dispute resolution system’, International Affairs, 79:4 (2003), 783–800.
Attaran, A and Gillespie-White, L, ‘Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?’, Journal of American Medical Association, 286:1886 (2001).
Attaran, A et al., ‘WHO, the Global Fund, and medical malpractice in malaria treatment’, The Lancet, 363:9404 (2004), 237–40.
Bacchetti, P et al., ‘Survival with AIDS in New York’, New England Journal of Medicine, 318:22 (1988), 1464.
Baker, B, ‘Analysis and Response to WTO Action Regarding Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health.’ United Nations Millennium Goals Project Task Force No 5: Infectious Diseases and Access to Essential Medicines, Sub Group Access to Essential Medicines (2003).
Baker, B and Ombaka, E, ‘The danger of in-kind drug donations to the Global Fund’, The Lancet, 378 (2009), 1218–21.
Balasubramaniam, K, ‘Access to medicines: Patents, prices and public policy – consumer perspectives’, paper presented at Oxfam International Seminar on Intellectual Property and Development: What future for the WTO TRIPS Agreement? Brussels, 20 March 2001.
Balter, M, ‘UN readies new global AIDS plan’, Science, 266:5189 (1994), 1312–13.
Barry, M, ‘The influence of the US tobacco industry on the health, economy, and environment of developing countries’, New England Journal of Medicine 324 (1991), 917–20.
Bartlet, S, ‘The TRIPS Agreement and public health’, The Journal of World Intellectual Property, 3 (2003).
Barton, John H, ‘TRIPS and the global pharmaceutical market’, Health Affairs, 23:3 (2004).
Bartsch, S, ‘The Global Fund to Fight AIDS, Tuberculosis and Malaria: Establishment, current issues and future challenges’, Global Health Governance, 7 (2005).
Bassett, M and Mhloyi, M, ‘Women and AIDS in Zimbabwe: The making of an epidemic’, International Journal of Health Services, 22:1 (1991), 143–56.
Bayer, R, ‘AIDS, privacy and responsibility’, Daedalus, 118:3 (1989), 79–99.
Bayer, R and Fairchild-Carrino, A, ‘AIDS and the limits of control: Public health orders, quarantine, and recalcitrant behaviour’, American Journal of Public Health, 83:10 (1993), 1471–6.
Baylies, C, ‘HIV/AIDS and older women in Zambia: Concern for self worry over daughters towers of strength’, Third World Quarterly, 23:2 (2002), 351–75.
Beetham, D, ‘What future for economic and social rights?’, Political Studies, 43 (1996), 41–6.
Beigbeder, Y, in Dantes, Octavio Gomez (ed), International Health in the 20th Century: Agenda Negotiations and Agreements (Salud Publici de Mexico, 2003) 45.
Bello, W, ‘Learning from Doha: A civil society perspective from the south’, Global Governance, 8 (2002) 273–5.
Birn, A E, ‘Gates’ grandest challenge: Transcending technology as a public health ideology’, The Lancet, 366:9484 (2005), 514–19.
Bletcher, S A, ‘The legal significance of re-citation of General Assembly resolutions’, American Journal of International Law, 63 (1969), 444–53.
Blutman, L ‘In the trap of a legal metaphor: International soft law’, International Comparative Law Quarterly, 59 (2010), 605–24.
Bop, C, ‘Women in conflicts, their gains and losses’, in Amnesty International, Marked for Death: Rape Survivors Living with HIV/AIDS in Rwanda (5 April 2004), AI Index: AFR 47/007/2004.
Bothe, M, ‘Legal and non legal norms – a meaningful distinction in international relations?’, Neth YB Int’l, 11 (1980), 65, 69.
Bown, C, ‘Developing countries as plaintiffs and defendants in GATT/WTO trade disputes’, The World Economy, 27:1 (2004), 56–80.
Bown, C, ‘On the economic success of GATT/WTO dispute settlement’, The Review of Economics and Statistics, (2003).
Bown, C, ‘The economics of trade disputes, the GATTS Article XXIII and the WTO dispute settlement understanding’, Economics and Politics, 14:3 (2002), 283–323.
Boyd, M F, ‘Malaria: Retrospect and prospect’, American Journal of Tropical Medicine and Hygiene, 19 (1939), 1–6.
Bradsher, K and Andrews, E, ‘US says Bayer will cut the cost of its anthrax drug.’ New York Times (24 October 2001).
Brentlinger, P E, Behrens, C B and Kublin, J G, ‘Challenges in the prevention, diagnosis, and treatment of malaria in human immunodeficiency virus infected adults in sub-Saharan Africa’, Archives of Internal Medicine, 167:17 (2007), 1827–36.
Brett, R ‘Human rights and NGOs at the United Nations’, Political Studies, XLIII (1995), 96–110.
Brimnes, N, ‘BCG vaccination and WHO’s global strategy for tuberculosis control 1948–1983’, Social Science and Medicine, 67 (2008), 863–73.
Brittain, V, ‘“More die of AIDS than war in Africa,” says Kofi Annan’, The Guardian (14 March 2000).
Brown, G W, ‘Safeguarding deliberative governance: The case of the Global Fund to Fight AIDS, Malaria and Tuberculosis’, Review of International Studies, 36 (2010), 511–30.
Brown, K, ‘Descriptive and normative ethics: Class, context and confidentiality for mothers with HIV’, Social Science and Medicine, 36:3 (1993), 195–202.
Brownlie, I, ‘The legal status of natural resources’, Recueil des Cours 12:261 (1992), 249–62.
Brugha, R, ‘The Global Fund at three years: Flying in a crowded space’, Tropical Medicine and International Health, 10:623 (2005), 626–42.
Brugha, R and Starling, M et al., ‘The Global Fund: Managing great expectations’, The Lancet, 364:95 (2004), 100.
Bruyn, Mde, ‘Women and AIDS in developing countries’, Science & Medicine, 34:3 (1992), 249–63.
Burris, S, Drahos, P and Shearing, C, ‘Nodal governance’, Australian Journal of Legal Philosophy, 30 (2005), 30.
Busch, M L and Reinhardt, E, ‘Developing countries and General Agreement on Tariffs and Trade/World Trade Organization Dispute Settlement’, Journal of World Trade, 37:4 (2003), 719–35.
Butler, M and Hauser, H, ‘The WTO dispute settlement system: A first assessment from an economic perspective’, Journal of Law, Economics and Organization, 6:2 (2000), 503–33.
Buve, A, Bishakwabo-Nsarhaza, K and Mutugadur, A, ‘The spread of HIV-1 infection in sub Saharan Africa’, The Lancet, 359 (2002), 2011–7.
Caldwell, J, Caldwell, P and Quiggin, P, ‘The social context of AIDS in sub-Saharan Africa’, Population and Development Review, 15:2 (1989), 185–234.
Cameron, E, First Jonathan Mann Memorial Lecture: The Deafening Silence of AIDS. X111 International AIDS Conference, Durban South Africa, 9–14 July 2000. Available at www.tac.org.za/newsletter/20000/ns000717.txt. last accessed 20 October 2012. Campbell, C, ‘Women and AIDS’, Social Science and Medicine, 30:4 (1990), 407–15.
Carlson, R, Boyd, K and Webb, D, ‘The revision of the Declaration of Helsinki: Past, present and future’, British Journal of Clinical Pharmacology, 57:6 (2004), 695–713.
Carovano, K, ‘More than mothers and whores: Redefining the AIDS prevention needs of women’, International Journal of Health Services 21:1 (1991), 131–42.
Centers for Disease Control and Prevention, ‘Emergence of mycobacterium tuberculosis with extensive resistance to second-line drugs – worldwide, 2000–2004’, MMWR Morb Mortal Wkly Rep, 55 (2006), 301–5.
Chapman, A, ‘A violations approach for monitoring the international covenant on economic social and cultural rights’, Human Rights Quarterly, 18 (1996), 23–66.
Charnovitz, S, ‘The legal status of the Doha Declarations’, Journal of International Economic Law, 5:1 (2002) 210–1.
Checkel, J T, ‘Norms, institutions and national identity in contemporary Europe’, International Studies Quarterly, 43 (1999), 86–7.
Checkel, J T, ‘“Why comply?” Social learning and European identity change’, International Organization, 55 (2001), 555.
Chen, E et al., ‘Human resources for health: Overcoming the crisis’, The Lancet, 364 (2004), 1984–90.
Chestnut, M, ‘Cuban AIDS centers prompt accusations: Are they luxury apartments or concentration camps?’, Advocate, 585 (1991), 48.
Chien, C, ‘Cheap drugs at what price to innovation: Does compulsory licensing hurt innovation?’, Berkeley Technology Law Journal, 18:3 (2003), 853–907.
Chinkin, C, ‘The challenge of soft law: Development and change in international law’, ICLQ, 38 (1989), 850–66.
Christiansen, E, ‘Adjudicating non justiciable rights: Socio-economic rights and the South African constitutional court’, Columbia Human Rights Law Review, 38:350 (2006–2007), 321–86.
Cini, M, From soft law to hard law? Discretion and rule making in the Commission’s State Aid regime. European University Institute Working Paper RSC200/35. (2000).
Clark, A M, Freidman, E J and Hochstetter, K, ‘The sovereign limits of global civil society: A comparison of NGO participation in UN World Conferences on the environment, human rights, and women’, Journal of World Politics, 51:1 (1998), 1–35.
Cleary, E W, ‘Res judicata re-examined’, Yale Law Journal, 57 (1947–1948), 339.
Cohen, C P, ‘The role of NGOs in drafting the Convention on the Rights of the Child’, Human Rights Quarterly, 12:1 (1990), 137–47.
Conference of Experts on the Rational Use of Drugs (1985) The Role of WHO in the Transfer and Dissemination of Information on Drug Quality Safety and Efficacy, Prepared for the conference of experts on the rational use of drugs, Nairobi, Kenya 25–29 November 1985 (WHO/CONRAD/WP/1.2).
Cornman, H and Duvvury, N, Civil society participation in Global Fund governance. ICRW Working Paper Series. (2005).
Correa, C, ‘Implications of bilateral free trade agreements on access to medicines’, Bulletin of the World Health Organization, (2006), 399–404.
Correa, C and Mathews, D, ‘The Doha Declaration ten years on and its impact on access to medicines and the right to health,’ United Nations Development Programme Bureau for Development Policy, 20 December 2011, 20.
Cotton, P, ‘Human rights as critical as condoms against HIV’, Journal of American Medical Association, 272:10 (1994), 758.
Craig, S and Macklem, P, ‘Constitutional ropes of sand or justiciable guarantees? Social rights in a new South African Constitution’, University of Pennsylvania Law Review, 141:1 (1992), 3–147.
Croft, S L, ‘Public-private partnerships, from here to there’, Transactions of the Royal Society of Tropical Medicine and Hygiene, 99:1 (2005), 9–14.
Cullet, P, ‘Patents and medicines: The relationship between TRIPS and the human right to health’, International Affairs, 79:1 (2003), 139–60.
Dalton, H, ‘AIDS in blackface’, Daedalus, 118:3 (1989), 205–27.
D’Amato, A, ‘Is international law really law?’, North Western Law Review, 79 (1985).
D’Amato, A, ‘The neo positivist concept of international law’, American Journal of International Law, 59 (1965), 321–2.
Dankwa, V and Flinterman, C et al., ‘Commentary to the Maastricht Guidelines on violations of economic social and cultural rights’, Human Rights Quarterly, 20:3, 705–30.
Dantes, O G, ‘International health in the 20th century: Agenda negotiations and agreements’, Salud Publici de Mexico, 45:4 (2003), 316–32.
Danziger, R, ‘An epidemic like any other? Rights and responsibilities in HIV prevention’, British Medical Journal, 312:7038 (1996), 1083–4.
Danzon, P M and Towse, A, ‘Differential pricing for pharmaceuticals: Reconciling access, R&D and patents’, International Journal of Health Care Finance and Economics, 3 (2003), 183–205.
D’Aspremont, J, ‘Softness in international law: A self serving quest for new legal materials’, European Journal of International Law 19:5 (2008), 1075–93.
Decosas, J, ‘Fighting AIDS or responding to the epidemic: Can public health find its way?’, The Lancet, 343:8906 (1994), 1146.
Decosas, J, Kane, F, Anarfi, J K et al., ‘Migration and AIDS’, The Lancet, 346:8978 (1995), 826–8.
Del Ponte, K, ‘Note forming customary international law, an examination of the WHO international code of marketing of breast milk substitutes’, Boston College International & Comparative Law Review, 377 (1982), 377–403.
Devaiah, V H, ‘TRIPS Patents and Public Policy’. Accessible from www.infochageindia.org last accessed 20 July 2010. Djoman, G, Roels, Theirry and Chirba, Terrence, ‘HIV/Drugs Access Initiative’ Preliminary Report 1998–2000. Accessible from df.usaid.gov/pdf_docs/Pnacl667.pdf last accessed 20 March 2016. Dobrianksy, P, ‘US human rights policy: An overview’, US Department of State Current Policy, 1091 (1998), 2–3.
Donohoe, M, ‘Cigarettes: The other weapons of mass destruction: The framework convention on tobacco control treaty’. Medscape article available at www.medscape.com/viewarticle/501586_3 last accessed 28 December 2016. Dorcucci, M, Balducci, M, Pezotti, P, Sinicco, A, Alberici, F and Rezza, G, ‘Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: Estimates of the population effect of treatment’, Journal of Acquired Immune Deficiency Syndrome, 22:1 (1999), 65–70.
Downs, G and Jones, A M, ‘Reputation, compliance and international law’, Journal of Legal Studies, 31 (2002), 95.
Dräger, S, Gedik, G and Dal Poz, M, ‘Health workforce issues and the Global Fund to Fight AIDS Tuberculosis and Malaria: An analytical review’, Human Resources for Health, 4 (2006). Available from www.human-resources-health.com/content/4/1/23 last accessed 12 April 2011. Drahos, Peter, ‘Four lessons for developing countries from the trade negotiations over access to medicines’, Liverpool Law Review, 28:1 (2007), 11–39.
Dunoff, J, ‘The misguided debate over NGO participation at the WTO’, Journal of International Economic Law, 1:3 (1998), 434–9.
Dunoff, J, ‘The Universal Declaration at 50 and the challenge of the global markets: Trading away the human rights principle’, Brooklyn Journal of International Law, 25 (1999), 51.
Dybul, M, Fauci, A S, Bartlett, J G, Kaplan, J and Pau, A K, ‘Panel on Clinical Practices for Treatment of HIV Guidelines for using antiretroviral agents among HIV-infected adults and adolescents’, Annals of Internal Medicine, September 137:5–2 (2002), 381–433.
Dyer, G and Michaels, A, ‘Anthrax scare raises awkward patent questions’, Financial Times October 2001.
The Economist, ‘Cleaning up: Can the Global Fund restore its reputation as the best and cleanest in the aid business?’, Available at www.economist.com/node/18176062 last accessed 20 March 2011. Elias, O and Lim, C, ‘“General principles of law”, “soft” law, and identification of international law’, Netherlands Year Book of International Law, 28 (1997), 3–49.
Elliot, R, ‘Pledges and pitfalls: Canada’s legislation on compulsory licenses of pharmaceuticals for export’, International Journal of Intellectual Property Management, 1 (2006), 94.
Emily, N G and Clare Kohler, J, ‘Finding flaws: The limitations of compulsory licensing for improving access to medicines – An international comparison’, Health law Journal, 16 (2008), 151.
Engelberg, A B, ‘Special patent provisions for pharmaceuticals: Have they outlived their uselessness? A political legislative and legal history of US law and observations for the future’, The Journal of Law and Technology, 39 (1998–1999), 389.
Esty, D C, ‘Global governance at the supranational scale globalizing administrative law’, Yale Law Journal, 115 (2006), 1490-1563.
Esty, D C, ‘Non governmental organisations at the World Trade Organization cooperation, competition or exclusion’, Journal of International Economic Law, 1:123–147.
Evans, T, ‘A human right to health?’, Third World Quarterly, 23:2 (2002), 200.
Eya, N C, ‘The role of non-governmental organizations in the promotion and protection of human rights’, Bulletin of Human Rights, 90 (1999), 50–83.
Farmer, P, ‘Medicine and social justice’, America, 173:2 (1995), 13–7.
Farmer, P, ‘On suffering and structural violence: A view from below’, Daedalus, 125:1 (1996), 261–83.
Farmer, P and Kim, J, ‘Anthropology, accountability, and the prevention of AIDS’, Journal of Sex Research, 28:2 (1991), 203–21.
Farmer, P and Kleinman, A, ‘AIDS as human suffering’, Daedalus, 118:2 (1989). 135–62.
Farmer, P, Zierler, S and Rodriquez, W, ‘Women, poverty and AIDS: On scholarship and social justice’, paper presented at the Conference on HIV Infection in Women: Setting a New Agenda (Washington, DC, 22–24 February 1995).
Farmer, P et al., ‘Community based approaches to HIV treatment in resource poor-settings’, The Lancet, 358 (2001).
Ferraz, O, ‘Between usurpation and abdication? The right to health in the courts of Brazil and South Africa’. Available from http://ssrn.com/elegal papers=1458299 last accessed 12 January 2016 Ferraz, Octavio, ‘The right to health in the courts of Brazil: Worsening health inequities?’, HHR, 11:2 (2009), 33–45.
Fiddler, D P, ‘Globalization, international law and emerging infectious diseases’, Emerging Infectious Diseases, 2:77 (1996), 77–84.
Fiddler, D P, ‘The future of the World Health Organization: What role for international law?’, Vanderbilt Journal of Trans National Law, 1 November 31:5 (1998), 1080–103.
Fiddler, D P, ‘The role of international law in the control of emerging infectious diseases’, Bull Inst Pasteur, 95 (1997), 57–72.
Field, Thomas G Jr., ‘Pharmaceuticals and intellectual property: Meeting needs throughout the world’, Journal of Law and Technology, 31 (1990), 3–14.
Finnemore, M and Sikkink, K, ‘International norm dynamics and political change’, International Organization, 52:4 (1998), 887–917.
Finnemore, M and Toope, S, ‘Alternatives to “legalization”: Richer views of law and politics’, Int’l Org, 55:3 (2001), 742–5.
Fischl, M A et al., ‘The efficacy of azidothymine (AZT) in the treatment of patients with AIDS and AIDS related complex. A double blind placebo controlled trial’, New England Journal of Medicine, 317 (1987), 185–91.
Fisher, W W III and Rigamonti, C P, ‘The South Africa AIDS controversy: A case study in patent law and policy’, Harvard Law School, The Law of Business and Patents, 12 (2005), 1–56.
Fitzmaurice, G, ‘The law and procedure of the International Court of Justice’, Baltic Yearbook of International Law, 29 (1952), 55.
Flood, C M and Gross, A, ‘Litigating the right to health: What can we learn from a comparative law and health care systems approach?’, Health and Human Rights, 2:16 (2014), 62–72.
Footer, M, ‘The (Re)turn to “soft law” in reconciling the antimonies in WTO law’, Melbourne Journal of International Economic Law, 11 (2010), 241–76.
Ford, N, ‘Patents access to medicines and the role of non governmental organizations’, Journal for the Generic Medicines, 1:2 (2004), 137–45.
Ford, N and Piedangnel, J M, ‘WHO must continue its work on access to medicines in developing countries’, The Lancet, 361:9351 (2003), 3.
France, T, Ooms, G and Rivers, B, ‘The GFTAM: Which countries owe, and how much?’, International Association of Physicians in AIDS Care Monthly, 8 (2002), 131–41.
Frankenberg, R, ‘What identity’s at risk? Anthropologists and AIDS’, Anthropology in Action, 12 (1992), 6–9.
French, N, Nakiyingi, J, Lugada, E et al., ‘Increasing rates of malarial fever with deteriorating immune status in HIV-1 infected Ugandan adults’, AIDS, 15 (2001), 899–906.
Fuller, L, ‘The forms and limits of adjudication’, Harvard Law Review, 92:353 (1978), 394–8.
Fullilove, M, Lown, A and Fullilove, R E, ‘Crack ’hos and Skeezers: Traumatic experiences of women crack users’, Journal of Sex Research, 29:2 (1992), 275–87.
Fuss, S and Zeegers, D, ‘Reporting of AIDS and human immunodeficiency virus infection: A worldwide review of legislative and regulatory patterns and issues’, AIDS and Public Policy Journal, 5:1 (1990), 32–6.
Gandhi, N R, Moll, R, and Sturm, A W et al., ‘Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa’, The Lancet, 368 (2006), 1575–80.
Gandhi, N R N et al., ‘Multi-drug resistant and extensively drug resistant tuberculosis: a threat to global control of tuberculosis’, The Lancet, 375 (2010), 1830–43.
Garattin, L, and Tediosi, F, ‘A comparative analysis of generic markets in five European countries’, Health Policy, 51:3 (2000), 149.
Gardiner, R, ‘Revising the law of carriage by air: Mechanisms in treaties and contract’, International Comparative Law Quarterly, 47 (1998), 278–305.
GATFM, ‘Increased resources for the Global Fund but pledges fall short of the expected demand’, The Lancet, 376 (2010), 1439.
Gatter, P, ‘Anthropology, HIV and contingent identities’, Social Science and Medicine, 41:11 (1995), 1523–33.
Geshekter, C L, ‘Outbreak? AIDS, Africa and the medicalization of poverty: Is Africa facing a lethal pandemic?’, Transition, 67 (1995), 4–14.
Ghosh, S, ‘Pills, patents and power: State creation of gray markets as a limit on patent rights’, Florida Journal of International Law, 14 (2002), 217.
Ginsburd, T and McAdams, R, ‘Adjudicating in anarchy: An expressive theory of international dispute resolution’, William and Mary Law Review, 45 (2004), 1229–36.
Global Civil Society, ‘A comparison of NGO participation in the UN World Conferences’, World Politics, 51:1 (1998), 1–35.
Goetz, C J and Scott, R E, ‘The limits of expanded choice: An analysis of the interaction between express and implied contract terms’, California Law Review, 73 (1985), 261.
Gomez, M, ‘Social economic and cultural rights and human rights commissions’, Human Rights Quarterly, 17 (1995), 155–69.
Gruchalla-Weiserski, T, ‘A framework for understanding “soft law”’, McGill Law Journal, 30 (1984), 37, 40.
Gostin, L O, ‘The AIDS litigation project: A national review of court and human rights commission decisions, part II: Discrimination’, The Journal of the American Medical Association, 263:15 (1990), 2086.
Gottlieb, S, ‘Drug companies maintain astounding profits’, British Medical Journal, 324 (2002) 1054.
Grant, R and Koehane, R, ‘Accountability and abuses of power in world politics’, American Political Science Review, 9:1 (2005), 29–43.
Great Britain, House of Commons, (Session 2002–03) International Development Committee Third Report, the Humanitarian Crisis in Southern Africa, vol. 2 (HC116-II: London, 2003).
Green, J F, ‘Changing approaches to human rights, the United Nations 1954 and 1974’, Texas International Law Review, 12 (1977), 223.
Gregory, C and Shaffer, M P, ‘Hard vs “soft law”: Alternatives, complements and antagonists in international governance’, Minnesota Law Review, 715: (2010), 706–16.
Griffin, M T, ‘AIDS drugs and the pharmaceutical industry, a need for reform’, American Journal of Law and Medicine, 17 (1991), 363–78.
Grousse Ruse Khan, H M, ‘The role of chairman’s statements in the WTO’, Journal of World Trade, 41:3 (2007), 475.
Guzman, A, ‘A compliance based theory of international law’, California Law Review, 90:6 (2002), 1823, 1841.
Guzman, A and Meyer, T L, ‘Explaining soft law’, Journal of Legal Analysis, 2:1 (2009), 16.
Guzman, A and Meyer, T L, ‘International soft law’, Journal of Legal Analysis, 3 (2010).
Guzman, A and Simmons, B, ‘To settle or to empanel? An empirical analysis of litigation and settlement at the World Trade Organization’, Journal of Legal Studies, 31, (2002), 205–35.
Haigler, T E Jr., ‘Reduced dosage cuts cost of AIDS drug’, New York Times, Editorial Desk. 16 September 1989, late edition.
Hall, S, ‘The persistent spectre: International order and the limits of legal positivism’, European Journal of International Law, 12 (2001), 272.
Handl, G et al., ‘“A hard look at soft law”, Proceedings of the annual meeting of the American Society of International Law, ASIL, 82 (1988), 371–95.
Haochen, S, ‘The road to Doha and beyond: Some reflections on the TRIPS Agreement and public health’, Society of International Law, 15 (2004), 123–50.
Harmon, A and Pear, R, ‘Canada overrides patent for Cipro to treat anthrax’, New York Times, 19 October 2001.
Harries, A D et al., ‘Preventing antiretroviral anarchy in sub-Saharan Africa’, The Lancet, 358:9279 (2001), 410–14.
Harrington, J A, ‘AIDS, public health and the law. A case of structural coupling?’, European Journal of Health Law, 6 (1999), 211–32.
Hart, H L A, ‘Definition and theory in jurisprudence’, Law Quarterly Review, 70 (1958), 37–60. Reprinted in Essays in Jurisprudence and Philosophy. (Clarendon Press, Oxford, 1983) 21–48.
Heimer, C, ‘Soft law, hard science and the politics of health: From scientific claims about HIV to a moral obligation to treat’. Brown Legal Studies Seminar, The Watson Institute of International Studies. (2008).
Heise, L and Christopher, E, ‘Transforming AIDS prevention to meet women’s needs: A focus on developing countries’, Social Science and Medicine, 40:7 (1995), 931.
Helfer, L R, ‘Regime shifting: The TRIPS Agreement and new dynamics of intellectual property lawmaking’, Yale Journal of International Law, 29 (2004), 23–4.
Hempelmann, E and Krafts, K, ‘Bad air, amulets and mosquitoes: 2,000 years of changing perspectives on malaria’, Malaria Journal, 12:1 (2013), 213. doi:10.1186/1475–2875-12–232. PMC 3723432. PMID 23835014.
Henderson, D, ‘Eradication: Lessons from the past’, Morbidity and Mortality Weekly Report, 48: supplement 1 (1999), 16.
Henry, D and Lexchin, J, ‘The pharmaceutical industry as medicines provider’, Medicines Society and Industry, 3 (2002), 1592.
Hestermeyer, H P, ‘Access to medication as a human right’, Max Planck Yearbook of United Nations Law, 8 (2004), 101–80.
Heywood, M, ‘Drug access, patents and global health: “Chaffed and waxed sufficient”’, Third World Quarterly, 23 (2002), 217.
Hiroaki, M et al., ‘Credit government scientists with developing anti-AIDS drug’, New York Times (29 September 1989).
Hongju Koh, H, ‘Bringing international law home’, Houston Law Review, 35 (1998), 623.
Hopf, T, ‘The promise of constructivism in international relations theory’, International Security, 23:1 (1998), 175.
Howse, R, ‘The Canadian Generic Medicines Panel: A dangerous precedent in dangerous times’, Journal of World Intellectual Property, 3:403–507.
Huston, P and Paterson, R, ‘Withholding proven treatment in clinical research’, New England Journal of Medicine, 345:12 (2001), 915–9.
Jacobson, M A and French, M, ‘Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy’, AIDS Journal, 12 (1998), 157–63.
Jamar, Stephen D, ‘The international human right to health’, Southern University Law Review, 21:1 (1994), 24.
Jürgen, R, HIV/AIDS in Prisons: Final Report Project on Legal and Ethical Issues raised by AIDS. Canadian HIV/AIDS Legal Network and Canadian AIDS Society Montreal. (1996).
Kaleba, N, ‘We miss you all’ (Harare 1991) 66 Le Quotidien, Paris 29 May 2004.
Kaufmann, S E, and Gagenbacher, M, ‘Recombinant live vaccine candidates against tuberculosis’, Current Opinion in Biotechnology, 23 (2012), 900–7.
Kaufmann, S E, Hussey, G and Lambert, P H, ‘New vaccines for tuberculosis’, The Lancet, 375 (2010), 85–94.
Kelly, J, St. Lawrence, J, Smith, J et al., ‘Stigmatization of AIDS patients by physicians’, American Journal of Public Health, 77:7 (1987), 789–91.
Kelsen, H, ‘Theorie du droit international public’, Collected Courses, 84:III (1952), 136.
Kennedy, M, ‘Two single undertakings: Can the WTO implement the results of a round?’, Journal of International Economic Law, 14 (2011), 77–120.
Kennedy, M, ‘When will the protocol amending the TRIPS Agreement enter into force?’, Journal of International Economic Law, 13:2 (2010), 461–2.
Kerouedan, D, ‘The Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria five-year evaluation policy changes’, Med Trop., 70 (2010), 19–27, https://factsreports.revues.org/635 last accessed 12 January 2016. Khor, M, ‘Patents, compulsory licences and access to medicines: Some recent experiences’, Intellectual Property Rights Series, 10 (2007), 1–25.
Klabbers, J, ‘The redundancy of “soft law”’, Nordic Journal of International Law, 65:16 (1996), 167–182.
Klabbers, J, ‘The undesirability of “soft law”’, Nordic Journal of International Law, 67 (1998), 381–91.
Knowledge Ecology International, Recent Examples of the Use of Compulsory Licences on Patents. 21 March 2007, KEI Research Note 2.
Köchler, H, ‘Ethical aspects of sanctions in international law’, Year Book of International Relations, 22 (1992), 1–36.
Koh, H H, ‘Why do nations obey international law?’, Yale Law Journal, 106 (1997), 2598–9.
Kongolo, T, ‘Public interest versus pharmaceutical industry’s monopoly in South Africa’, Journal of World Intellectual Property, 4 (2001), 609–27.
Koskenniemi, M, Fragmentation of international law: Problems caused by a diversification and expansion of international law. Report of the Study Group of the International Law Commission. 13 April 2006, A/CN4/L682.
Koskenniemi, M, ‘International law and hegemony: A reconfiguration’, Cambridge Review of International Affairs, 17:2 (2004), 197–218.
Krafts, K, Hempelmann, E and Skorska-Stania, A, ‘From methylene blue to chloroquine: A brief review of the development of antimalarial therapy’, Paristol Res, 11:4 (2012), 671–6.
Laiffer, D M, ‘Putting super back in the supervision of international banking post BCCI’. Fordham Law Review 60:470 (1992), 18.
Laing, R et al., ‘25 years of the WHO essential medicine lists: Progress and challenges’, The Lancet, 361:9370 (2003).
Laurie, P, Hintzen, P and Lowie, R, ‘Social economics obstacles to HIV/AIDS prevention and treatment in developing countries, the roles of the IMF and the World Bank’, AIDS Journal, 9:6 (1995), 539–46.
Lauterpacht, H, ‘The Universal Declaration of Human Rights’, British Yearbook of International Law, 25:354 (1948), 376.
Lee, L C, ‘The Basle Accords as ‘soft law’: Strengthening international banking supervision’, Virginia Journal of International Law, 39 (1998), 31.
Lichtenstein, C C, ‘Hard law vs soft law unnecessary dichotomy?’, International Lawyer, 35 (2001), 1433–41, 1443.
Liebenberg, S, ‘The value of human dignity in interpreting social economic and cultural rights’, South African Journal of Human Rights, 21 (2005), 21–26.
Ligon, B L B, ‘Dr Jonathan Mann: Champion for human rights in the fight against AIDS’, Seminars in Paediatric Infectious Diseases, 14:4 (October 2003), 314–22.
Lima, Viviane D et al., ‘Expanded access to highly antiretroviral therapy: A potentially powerful strategy to curb the growth of the HIV/AIDS epidemic’, J Infect Dis, 198 (2008), 59.
Ling, C Y, ‘Malaysia’s experience in increasing access to antiretroviral drugs: Exercising the “government use” option’. Third World Network, IPR Series 9. (2006). Available at www.twnside.org.sg/title2/IPR/IPRSO9.pdf last accessed 20 November 2010. Linros, A and Mehling, M, ‘Dispelling the chimera of self contained regimes, international law and the WTO’, European Journal of International Law, 16 (2005), 857–78.
London, L, ‘Health and human rights: What can ten years of democracy in South Africa tell us?’, Health and Human Rights Journal 8(1): (2006), 1–26.
McNair, Lord, ‘The functions and differing legal character of treaties’, British Year Book of International Law, 11 (1930), 100–18.
Lurie, P, Hintzen, P and Lowe, R, ‘Socioeconomic obstacles to HIV prevention and treatment in developing countries: The roles of the International Monetary Fund and the World Bank’, AIDS, 9:6 (1995), 539–46.
Maleche, A and Day, E, ‘Right to health encompasses essential generic medicines: Challenging the 2008 anti-counterfeit act in Kenya’, Health and Human Rights Journal, 2:16 (2014).
Maskus, K E, ‘Parallel importing in pharmaceuticals: Implications for competition and prices in developing countries’, Final report to the World Intellectual Property Organisation (2001). Available from www.wipo.int/about-ip/en/studies/pdf/ssa_maskus_pi.pdf last accessed 2 January 2016. Mattei, U, ‘Hard code now!’, Global Jurist Frontiers, Art. 1 2:1 (2002), 107–15.
Matthews, D, ‘Is history repeating itself? The outcome of the negotiations on access to medicines, the HIV/AIDS pandemic and intellectual property rights in the World Trade Organization’, Law Social Justice and Global Development, 1:1(2004).
Matthews, D, ‘WTO decision on implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health: A solution to essential medicines problem’, JIEL, 7:1 (2004), 77.
McCormick, J, Neil, M and Mitchell, J, ‘Human rights violations, umbrella concepts and empirical analysis’, World Politics, 49:4 (1997), 510–25.
McGregor, S, ‘No drugs yet approved by former pledge to Africa’, Embassy Magazine, 17 May 2006.
Mecurio, B and Tyagi, M, ‘Treaty interpretation in WTO dispute settlement: The outstanding question of the legality of local working requirements’, Minnesota Journal of International Law, 19:2 (2010), 287.
Mgbeoji, I, ‘The juridical origins of the international patent system: Towards a histography of the role of patents in industrialisation’, Journal of the History of International Law, 5 (2003), 403–422.
Mitsuya, H, Weinhold, K J, Furman, P A et al., ‘3′-azido-3′deoxythymidine (BWA509U): An antiviral agent that inhabits the infectivity and cytopathy-associated virus in vitro’, Proceedings of the National Academy of Sciences, 82 (1985), 7096–100.
Morgenthau, H, ‘Positivism, functionalism and international law’, American Journal of International Law, 34 (1940), 260.
MSF, ‘Neither expeditious nor a solution: The WTO August 30th Decision is unworkable’, An illustration through Canada’s Jean Chretien Pledge to Africa. Presented at the XVI International AIDS Conference, Toronto, August 2006.
Mwalimu, U, ‘Imperfections of WTO/TRIPS in East Africa – With special emphasis on pharmaceutical patents’, Paper for Economics and Social Research Foundation Workshop on Globalization and East Africa, 15–6.
Nabili, A, ‘International patent rights in a post Doha world’, International Trade Law Journal, 11:57 (2002), 57–84.
Najera, J A, Gonzalez-Silva, M and Alonso, P L, ‘Some lessons for the future from the Global Malaria Eradication’, PLoS Med, 8:1 (1955–1969), 1–7.
Nicols, P M, ‘Extension of standing in the World Trade Organization’, University of Pennsylvania Journal of International Economic Law, 17 (1996), 860–6.
Njuguna, J and Qader, S S, ‘Challenges associated with scaling up artemisinin combination therapy in sub-Saharan Africa. A review article’, Libyan Journal of Medicine, 3:1 (2008), 42–8.
Novogrodsky, N, ‘The duty of treatment: Human rights and the HIV/AIDS pandemic’, Yale Human Rights Development Law Journal, 12:1 (2009), 15.
Nyazema, N and Khoza, S et al., ‘Anti retroviral (ARV) utilisation in Harare’, Central African Journal of Medicine, 46:89 (2000), 89–93.
Oeter, S, ‘International law and general systems theory’, GYIL, 44 (2001), 72–95.
Okorosobo, T et al., ‘Economic burden of malaria in six countries of Africa’, European Journal of Business and Management, 3:6 (2011), 42–63.
Okuonzi, S A, ‘The Global Fund: preparing for the Messiah?’, Health Policy and Planning, 19:1 (2004), 55–6.
Ooms, G, ‘Health development versus the medical relief: The illusion versus the irrelevance of sustainability’, PLoS Med, 3:8 (2006), 1202–05.
Ooms, G and Hammonds, R, ‘Correcting globalisation in health: Transnational entilements versus the ethical imperative of reducing aid-dependency’, Public Health Ethics, 1:2 (2008), 154–70.
Ortino, F and Ulrich, E, ‘The world dispute settlement system 1995–2003’, Studies in Transnational Economic Law, 18 (2006), 422–3.
Ostergard, R L Jr., ‘Intellectual property; A universal human right’, Human Rights Quarterly, 21 (1999), 156.
Otto, D, ‘Non-governmental organizations in the United Nations system. The emerging role of international civil society’, Human Rights Quarterly, 18:1 (1996), 107–41.
Oxfam, ‘Salt, sugar, and malaria pills: How the Affordable Medicine Facility–malaria endangers public health’, Oxfam Briefing Paper, 163 (24 October 2012).
Packard, R M, ‘“No other logical choice”: Global malaria eradication and the politics of international health the post-war era’, Parassitologia, 40 (1998), 217–29.
Palca, J, ‘African AIDS: Whose research rules?’, Science, 250:4978 (1990), 199–200.
Payandah, M, ‘With great power comes great responsibility? The concept of the responsibility to protect within the process of international law making’, Yale Journal of International Law, 35:469 (2010), 508–13.
Pecoul, B et al., ‘Access to essential drugs in developing countries: A lost battle?’, Journal of the American Medical Association, 281 (1999), 36.
Phillip, A, ‘Ships passing in the night: The current state of the human rights and development debate seen through the lens of the Millennium Development Goals’, Human Rights Quarterly, 27 (2005), 755–829.
Piot, P, ‘Interview with G Brown, “Safeguarding deliberative global governance: The case of the Global Fund to Fight AIDS, Tuberculosis and Malaria”’, Review of International Studies, 36 (2010), 511–8.
Piot, P, ‘New UN program promotes multi-sectoral approach to AIDS prevention’, AIDS Captions, 3:1 (1996), 34–7.
Pogge, T, ‘Access to medicines’, Public Health and Ethics, 1:2 (2008), 73–82.
Pronto, A N, ‘Some thoughts on international law making’, European Journal of International Law, 19:3 (2008), 601–16.
Quinn, S C, ‘AIDS and the African-American woman: The triple burden of race, class, and gender’, Health Education Quarterly, 20:3 (1993), 305–20.
Qunn, W S, ‘Actions intentions and consequences, the doctrine of the double effect’, Philosophy and Public Affairs, 11 (1989), 334–51.
Raustiala, K and Victor, D G, ‘Conclusions in the implementation and effectiveness of international environmental commitment’, Theory and Practice, 659 (2002), 684–86.
Raviglone, M C and Pio, A, ‘Evolution of WHO policies for tuberculosis control, 1948–2001’, The Lancet, 359 (2002), 775–880.
Reamer, F, ‘AIDS and social work: The ethics and civil liberties agenda’, Social Work, 38:4 (1993), 412.
Reichman, J H, ‘Universal minimum standards of intellectual property protection under the TRIPS component of the WTO Agreement’, International Law, 29 (1995), 345.
Reinhardt, E, ‘Adjudication without enforcement in GATT disputes’, Journal of Conflict Disputes, 45 (2001).
Richman, D D et al., ‘The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex’, New England Journal of Medicine, 317 (1987), 192–7.
Roberts, D, Curtis, C, Tren, R, Sharp, B, Shiff, C and Bate, R, ‘Malaria control and public health’, Journal of Emergency Infectious Diseases, 10 (2004), 1170–1.
Roberts, D R, Manguin, S and Mouchet, J, ‘DDT house spraying and re-emerging malaria’, The Lancet, 356 (2000), 330–2.
Roberts, D R, ‘Preventing malaria in endemic areas’, [Editorial] British Medical Journal, 335 (2007), 1001–2. doi: 10.1136/bmj.39370.673785.BE.
Robertson, R E, ‘Measuring state compliance with the obligation to devote the maximum available resources to realising social economic and cultural rights’, Human Rights Quarterly, 16 (1994), 693–714.
Robilant, A D, ‘Genealogies of soft law’, American Journal of Comparative Law, 54 (2006), 500.
Robinson, L, ‘Touring Thailand’s sex industry’, The Nation, 257:14 (1993), 492–6.
Rosand, E, ‘The Security Council as a global legislator: Ultravires or ultra innovative?’, Fordham Law Review, 28:42 (2005), 562.
Roth, K, ‘Defending economic social cultural rights: Practical issues faced by a human rights organization’, Human Rights Quarterly, 26 (2004), 6–73.
Ryan, M, Knowledge diplomacy: Global competition and the politics of intellectual property, Brookings Institution, Washington (1998).
Sachs, J et al., Closing the gap in a generation: Health equity through action on the social determinants on health. Commission on Social Determinants of Health, World Health Organization, 28 August (2008).
Salman, S, ‘International water disputes: A new breed of claims, claimants and settlement institutions’, Water International, 31 (2006), 2–12.
Schacter, O, ‘United Nations law’, The American Journal of International Law, 88:1 (1994), 2.
Schafer, A, ‘Resolving deadlock, Why international organizations introduce soft law’, European Law Journal, 12 (2006), 194.
Schaffer, G and Pollack, M, ‘Hard vs soft law alternatives, complements and antagonists in international governance’, Minnesota Law Review, 94 (2010), 706, 719.
Scharpf, F W, ‘The European social model’, Journal of Common Market Studies, 40 (2002), 645–65.
Scheper-Hughes, N, ‘AIDS and the social body’, Social Science and Medicine, 39:7 (1994), 991–1003.
Scheper-Hughes, N, ‘AIDS, public health, and human rights in Cuba’, The Lancet, 342:8877 (1993), 965.
Schiller, N G, ‘What’s wrong with this picture? The hegemonic construction of AIDS research in the US’, Medical Anthropology Quarterly, 6:3 (1992), 237–54.
Scholte, J A, Civil Society and Democracy in Global Governance. University of Warwick CSGR Working Paper No 65/01, (2001).
Schwartlander, B, Grubb, I and Perriens, J, ‘The 10 year struggle to provide anti retroviral treatment to people with HIV in the developing world’, The Lancet, 368 (2006), 541–56.
Scott, L, ‘Another step towards indivisibility: Identifying the key features of violations of economic, social and cultural rights’, Human Rights Quarterly, 20 (1998), 81–124.
Seidel, G, ‘The competing discourses of HIV/AIDS in sub-Saharan Africa: Discourses of rights and empowerment vs discourses of control and exclusion’, Social Science & Medicine, 36:3 (1993), 175.
Sekalala, S, ‘Normative considerations underlying global health financing: Lessons for the framework convention on global health’, Global Health Governance, 9:1 (2015), 22–40.
Sekalala, S, ‘Third world access to essential medicines and the WTO General Council Decision 2003’, KLG, 21:1 (2010), 172–92.
Sell, S K, ‘TRIPS and the access to medicine campaign’, Wisconsin International Law Journal, 20 (2002), 481.
Sell, S K, ‘TRIPS-plus free trade agreements and access to medicines’, Liverpool Law Review, 28 (2007), 41–75.
Sell, S K, ‘TRIPS was never enough: Vertical forum shifting FTA ACTA and TTP’, Journal of Intellectual Property Law, 18:2 (2011), 447–78.
Sell, S and Prakesh, A, ‘Using ideas strategically: The contest between business and NGO networks in intellectual property rights’, International Studies Quarterly, 48 (2004), 143–75.
Shanker, D, ‘Brazil, the pharmaceutical industry and the WTO’, Journal of World Intellectual Property, 5:1 (2002), 52–53.
Shapiro, D, ‘Courts legislatures and paternalism’, Virginia Law Review, 74:519 (1998), 551–5.
Sherer, R, ‘AIDS policy into the 1990s’, Journal of American Medical Association, 263: 14 (1990), 1972.
Shibuya, K et al., ‘WHO Framework Convention on Tobacco Control: Development of an evidence based global public health treaty’, British Medical Journal, 327 (2003), 154.
Siegel, R L, ‘AIDS and human rights’, Human Rights Quarterly, 18:3 (1996) 612.
Singer, M, ‘AIDS and the health crisis of the US urban poor: The perspective of critical medical anthropology’, Social Science and Medicine, 39:7 (1994), 931–48.
Singer, M, ‘AIDS and US ethnic minorities: The crisis and alternative anthropological responses’, Human Organization, 51:1 (1992), 89–95.
Sohn, L, ‘A short history of United Nations documents on human rights, in The United Nations and Human Rights’, Report of the Commission to Study the Organization of Peace, 18 (1968), 39.
Soni, A K, ‘From GPA to UNAIDS: Examining the evolution of the UN response to AIDS’, Essay presented to the Committee on Degrees in Social Studies for a BA Honors Degree (Harvard University, November 1998).
Sprinz, D and Vaatoranta, T, ‘The interest based explanation of international environment policy’, International Organization, 48:1 (1994), 77–105.
Strax, T E, ‘Ethical issues of treating patients with AIDS in a rehabilitation setting’, American Journal of Physical Medicine and Rehabilitation, 73:4 (1994), 293–5.
Subedi, S, ‘The road from Doha: The issues for the development round of the WTO and the future of international trade’, International and Comparative Law Quarterly, 52:2 (2003), 425–46.
Subramanian, A, ‘The AIDS crisis, differential pricing of drugs, and the TRIPS Agreement’, Journal of World Intellectual Property, 4 (2001), 323.
Sullivan, J and Luzuriaga, K, ‘Prevention of mother to child transmission of HIV infection’, Clin Infect Dis, 40 (2005), 466–7.
Sykes, A O, ‘TRIPS, pharmaceuticals, developing countries and the Doha solution’, John M Olin Law and Economics Working Paper, 140 (2002), 9.
Szreter, S, ‘Economic growth, disruption, deprivation, disease and death: On the importance of the politics of public health for development’, Population and Development Review, 23:4 (1997), 693–728.
T’Hoen, E, ‘TRIPS, pharmaceutical patents and access to essential medicines: A long way from Seattle to Doha’, Chicago Journal of International Law , 3:1 (2002), 27.
Tabert, H P, ‘Rethinking capital adequacy: The Basle accord and the new framework’, The Business Lawyer, 56:767 (2001), 779.
Tarakanta, J et al., ‘Antimalarial patent landscape: A qualitative and quantitative analysis’, Current Science, 103:10 (2012), 1162–74.
Tasioulas, J, ‘In defence of relative normativity: Communication values and the Nicaragua case’, Oxford Journal of Legal Studies, 16:1 (1996), 85–128.
Tauer, C, ‘AIDS: Human rights and public health’, Medical Anthropology, 10:2–3 (1989), 177–92.
Taylor, A L ‘Making the World Health Organization work: A legal framework for universal access to the conditions for health’, American Journal of Law and Medicine 18:4 (2002).
Taylor, A L ‘Making the World Health Organization work: A legal framework for universal access to the conditions for health’, American Journal of Law and Medicine, 18 (1992), 302–3.
Taylor, A et al., ‘Non binding legal instruments in governance: Lessons from the global AIDS reporting mechanism’, Journal of Law Medicine and Ethics, 42:1 (2014), 81.
Testimony of Haigler, T E, former president of Burroughs Wellcome, on the company’s research of AZT. ‘AIDS Issues (Part I): Cost and Availability of AZT.’ Subcommittee on Health and the Environment, House Committee on Energy and Commerce, 100th Congress. 10 March 1987.
Thomas, S and Quinn, S C, ‘The Tuskegee syphilis study, 1932 to 1972: Implications for HIV reduction and AIDS risk education programs in the Black community’, American Journal of Public Health, 81:11 (1991), 1498–505.
Trouiller, P et al., ‘Drug development for neglected diseases: A deficient market and a public-health policy failure’, The Lancet, 359:9324 (2002), 2188–94.
Trubek, D M Cottrell, P and Nance, M, Jean Monnet Working Paper 02/05, (2005).
Udwadia, Z F et al., ‘Totally drug resistant tuberculosis in India’, Clinical Infectious Diseases, 54 (2012), 579–81.
UNAIDS/WHO, ‘2007 AIDS epidemic update’, November 2007.
United Nations, ‘The Guiding Principles on Internally Displaced Persons E/CN/4/1998/53Add1’. (New York, 11 February 1998).
University of Toronto, International Human Rights Program, ‘Making Canada’s Access to Medicines Regime Work for Countries in Need: A Case Study on Ghana’, AIDS in Africa and the Access to Drugs Initiative (January 2007).
US Representative Joe Barton’s holding on Pandemic Flu Preparedness, House Energy and Commerce Committee, FDHC Political Transcripts, 8 November 2005 (LexisNexis News Database).
Van der Borght, S et al., ‘The accelerating access initiative: Experience with a multinational workplace programme in Africa’, Bulletin of the World Health Organisation, 87:10 (2009), 794–8.
Van der Borght, S et al., ‘Access to ARVs in the private sector in Africa, lessons from the field’, WHO Bulletin, 4 (2009).
Van der Borght, S et al., ‘The accelerating access initiative: Experience with a multinational workplace programme in Africa’, Bull World Health Org, 87:10 (2009), 794, 798.
Vanderon, P ‘The WTO decision on paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health: Making it work’, Journal of World Intellectual Property, 62 (2000), 1747–96.
Velazquez, G and Boulet, P, Globalization and Access to Drugs, Implications of the WTO/TRIPS Agreement. Health Economics and Drug Action Series No 7. Action Program on Essential Drugs (WHO, Geneva, November 1997).
Vignes, C-H, ‘The future of international health law: WHO perspectives’, Int’l Dig Health Leg, 40 (1989), 18.
Volansky, M J, ‘Achieving global health: A review of the World Health Organization’, Tulsa Journal of Comparative and International Law, 223 (2002–2003), 223–59.
Wafula, F, Agweyu, A and Macintyre, K, ‘Regional and temporal trends in malaria commodity costs: An analysis of Global Fund data for 79 countries’, Malaria Journal, 12 (2013), 466.
Waingberg, M A, ‘Generic HIV drugs – enlightened policy for global health’, New England Journal of Medicine, 352 (2005), 747–50.
Walker, K, ‘Cost-comparison of DDT and alternative insecticides for malaria control’, Medical and Veterinary Entomology, 14 (2000), 345–54.
Waning, B et al., ‘Global strategies to reduce the price of antiretroviral medicines: Evidence from transactional databases’, Bulletin of the World Health Organization, 87 (2009), 520–8.
Wastila, L J and Lasagna, L, ‘The history of zidovudine (AZT)’, Journal of Clinical Research and Pharmacoepidemiology, 4(1): (1990), 25–37.
Watson, P, ‘Legal theory, efficacy and validity in the developments of human rights norms in international law’, University of Illinois Law Forum, 609:11179 (1979), 610–40.
Waver, D, ‘Canada’s intellectual framework: A comparative overview’, Intellectual Property Journal, 17:125 (2004), 188.
Wawer, M J et al., ‘Rates of HIV-1 transmission per coital act by stage of HIV-1 infection in Rakai Uganda’, Journal of Infectious Diseases, 191 (2005), 1403–9.
Weil, P, ‘Towards a relative normativity in international law’, American Journal of International Law, 77 (1983), 413.
Wellens, K and Borchardt, G M, ‘Soft law in European community law’, European Law Review, 14 (1989), 267–321.
Whelan, D, A violations approach to protecting economic social and cultural rights. Conference paper presented at the ISA 49th Annual Convention, Bridging Multiple Divides. San Francisco (2008). Available at www.allacademic.com/meta/p251974-index.html last accessed 20 October 2011. WHO, ‘Drug information’, WHO Publications, 13:4 (1999).
WHO, ‘Intellectual property protection: Impact on public health’, WHO Drug Inf, 19:3 (2005), 3.
WHO, Re-examination of the global strategy of malaria eradication: Twenty-Second World Health Assembly Part 1 WHO Official Records No. 176 annex 13 (WHO Publications Geneva) 106–26.
WHO, Technical Report Series No 640, Seventeenth Report of the Malaria Expert Committee 1979 (WHO Publications, Geneva).
WHO, ‘The pricing and procurement of antiretroviral drugs: An observational study of data by the global fund’, Bulletin of the World Health Organization, 84 (May 2006) 393–8.
Willcox, M L and Bodeker, G, ‘Traditional herbal medicines for malaria’, (PDF). British Medicial Journal, 329:7475 (2004), 1156–9.
Williams, O D, ‘Access to medicines, market failure and market intervention: a tale of two regimes’, Global Public Health, 7:2 (2012), 127–43.
Williams, O D and Rushton, S, ‘Are the good times over? Looking to the future of global health governance’, Global Health Governance, 5:1 (2011), 1–16.
WTO, Council for Trade Related Aspects of Intellectual Property Rights. Special Discussion on Intellectual Property Rights and Access to Medicines 4, WTO Doc No IP/C/M31 (Restricted) July 10 2001.
WTO, Intellectual Property Decision Removes Final Patent Obstacle to Cheap Drug Imports. (Press release) 350 (03–4558). (August 2006).
Yamin, A E, ‘Not just a tragedy: Access to medications as a right under international law’, Boston Universit International Law Journal, 21 (2003), 325.
Yamin, A E, ‘Promoting health equity in health: What role for the courts?’, Health and Human Rights Journal, 2:16 (2014), 2.
Youde, J, ‘Is universal ARV access an emerging international norm?’, Journal of International Relations and Development, 11 (2008), 415–40.
Young, K G, ‘The minimum core of economic and social rights: A concept in search of content’, The Yale Journal of International Law, 33 (2003), 164.
Yu, P K, ‘Toward a non zero sum approach to resolving global intellectual property disputes: What we can learn from mediators, business strategists and international relations theorists’, University of Cincinnati Law Review, 70:569 (2001), 635.
Zion, D, ‘Justice as equitable power relations: Beyond the “standard of care” debate and the Declaration of Helsinki’, The American Journal of Bioethics, 3:2 (2003).